Document is current
Any future updates will be listed below
-
Authors
Bergen, Elisabeth S.
Friedrich, Alexander
Scherleitner, Peter
Ferreira, Pedro
Kiesel, Barbara
Widhalm, Georg
Kiesewetter, Barbara
Eckert, Franziska
Prager, Gerald W.
Preusser, Matthias
Berghoff, Anna S.
-
Funding
Funding for this research was provided by:
Medical University of Vienna
- License Information
-
More Information
Article History
Received: 30 December 2022
Accepted: 23 February 2023
First Online: 22 March 2023
Declarations
:
: ESB has honoraria for lectures, consultation or advisory board participation from Servier. BKiesew. received honoraria for lectures or advisory board participation from the following for-profit companies: from AAA, Boehringer Ingelheim, Eli Lilly, Ipsen, Janssen-Cilag, MSD, Novartis, Roche, Eli Lilly (all outside of the submitted work). FE received speaker’s fees from Dr. Sennewald Medizintechnik GmbH. GWP declares advisory roles for Merck, Amgen, Roche, Servier, Bayer, Pierre Fabre, MSD, BMS, AstraZeneca and Daiichi Sankyo. MP has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen, Adastra, Gan & Lee Pharmaceuticals. Anna Sophie Berghoff has research support from Daiichi Sankyo, Roche and honoraria for lectures, consultation or advisory board participation from Roche Bristol-Meyers Squibb, Merck, Daiichi Sankyo, AstraZeneca, CeCaVa as well as travel support from Roche, Amgen and AbbVie. All other authors declare no conflicts of interests.
